The Use of B-type Natriuretic Peptide (BNP) to Predict Closure of a Patent Ductus Arteriosus (PDA) in Premature Infants

Conditions

• Indomethacin Therapy
• Patent Ductus Arteriosus

Interventions

• PROCEDURE: Withhold standard INDO dose if BNP < 100 pg/ml

Sponsor

University of Virginia